These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 20303351)

  • 1. Dissociation between intrahepatic triglyceride content and insulin resistance in familial hypobetalipoproteinemia.
    Amaro A; Fabbrini E; Kars M; Yue P; Schechtman K; Schonfeld G; Klein S
    Gastroenterology; 2010 Jul; 139(1):149-53. PubMed ID: 20303351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonalcoholic fatty liver disease is associated with hepatic and skeletal muscle insulin resistance in overweight adolescents.
    Deivanayagam S; Mohammed BS; Vitola BE; Naguib GH; Keshen TH; Kirk EP; Klein S
    Am J Clin Nutr; 2008 Aug; 88(2):257-62. PubMed ID: 18689359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty liver and insulin resistance in children with hypobetalipoproteinemia: the importance of aetiology.
    Della Corte C; Fintini D; Giordano U; Cappa M; Brufani C; Majo F; Mennini C; Nobili V
    Clin Endocrinol (Oxf); 2013 Jul; 79(1):49-54. PubMed ID: 22789032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease.
    Smith GI; Shankaran M; Yoshino M; Schweitzer GG; Chondronikola M; Beals JW; Okunade AL; Patterson BW; Nyangau E; Field T; Sirlin CB; Talukdar S; Hellerstein MK; Klein S
    J Clin Invest; 2020 Mar; 130(3):1453-1460. PubMed ID: 31805015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in fatty acid kinetics in obese adolescents with increased intrahepatic triglyceride content.
    Fabbrini E; deHaseth D; Deivanayagam S; Mohammed BS; Vitola BE; Klein S
    Obesity (Silver Spring); 2009 Jan; 17(1):25-9. PubMed ID: 18948971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects.
    Korenblat KM; Fabbrini E; Mohammed BS; Klein S
    Gastroenterology; 2008 May; 134(5):1369-75. PubMed ID: 18355813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease.
    Fabbrini E; Mohammed BS; Magkos F; Korenblat KM; Patterson BW; Klein S
    Gastroenterology; 2008 Feb; 134(2):424-31. PubMed ID: 18242210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and insulin action in obese subjects with nonalcoholic fatty liver disease.
    Fabbrini E; Mohammed BS; Korenblat KM; Magkos F; McCrea J; Patterson BW; Klein S
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2727-35. PubMed ID: 20371660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity.
    Fabbrini E; Magkos F; Mohammed BS; Pietka T; Abumrad NA; Patterson BW; Okunade A; Klein S
    Proc Natl Acad Sci U S A; 2009 Sep; 106(36):15430-5. PubMed ID: 19706383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of adiposity, insulin resistance, and intrahepatic triglyceride content on insulin kinetics.
    Smith GI; Polidori DC; Yoshino M; Kearney ML; Patterson BW; Mittendorfer B; Klein S
    J Clin Invest; 2020 Jun; 130(6):3305-3314. PubMed ID: 32191646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease.
    Bril F; Barb D; Portillo-Sanchez P; Biernacki D; Lomonaco R; Suman A; Weber MH; Budd JT; Lupi ME; Cusi K
    Hepatology; 2017 Apr; 65(4):1132-1144. PubMed ID: 27981615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visceral adipose tissue tracks more closely with metabolic dysfunction than intrahepatic triglyceride in lean Asians without diabetes.
    Ding C; Chan Z; Chooi YC; Choo J; Sadananthan SA; Michael N; Velan SS; Leow MKS; Magkos F
    J Appl Physiol (1985); 2018 Sep; 125(3):909-915. PubMed ID: 29745794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease.
    Sullivan S; Kirk EP; Mittendorfer B; Patterson BW; Klein S
    Hepatology; 2012 Jun; 55(6):1738-45. PubMed ID: 22213436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased whole-body adiposity without a concomitant increase in liver fat is not associated with augmented metabolic dysfunction.
    Magkos F; Fabbrini E; Mohammed BS; Patterson BW; Klein S
    Obesity (Silver Spring); 2010 Aug; 18(8):1510-5. PubMed ID: 20395947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in ventricular structure and function in obese adolescents with nonalcoholic fatty liver disease.
    Singh GK; Vitola BE; Holland MR; Sekarski T; Patterson BW; Magkos F; Klein S
    J Pediatr; 2013 Jun; 162(6):1160-8, 1168.e1. PubMed ID: 23260104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic steatosis does not cause insulin resistance in people with familial hypobetalipoproteinaemia.
    Visser ME; Lammers NM; Nederveen AJ; van der Graaf M; Heerschap A; Ackermans MT; Sauerwein HP; Stroes ES; Serlie MJ
    Diabetologia; 2011 Aug; 54(8):2113-21. PubMed ID: 21547498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations Among Adipose Tissue Immunology, Inflammation, Exosomes and Insulin Sensitivity in People With Obesity and Nonalcoholic Fatty Liver Disease.
    Fuchs A; Samovski D; Smith GI; Cifarelli V; Farabi SS; Yoshino J; Pietka T; Chang SW; Ghosh S; Myckatyn TM; Klein S
    Gastroenterology; 2021 Sep; 161(3):968-981.e12. PubMed ID: 34004161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight loss reduces liver fat and improves hepatic and skeletal muscle insulin sensitivity in obese adolescents.
    Vitola BE; Deivanayagam S; Stein RI; Mohammed BS; Magkos F; Kirk EP; Klein S
    Obesity (Silver Spring); 2009 Sep; 17(9):1744-8. PubMed ID: 19498349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty liver in familial hypobetalipoproteinemia: triglyceride assembly into VLDL particles is affected by the extent of hepatic steatosis.
    Schonfeld G; Patterson BW; Yablonskiy DA; Tanoli TS; Averna M; Elias N; Yue P; Ackerman J
    J Lipid Res; 2003 Mar; 44(3):470-8. PubMed ID: 12562873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease.
    Luukkonen PK; Dufour S; Lyu K; Zhang XM; Hakkarainen A; Lehtimäki TE; Cline GW; Petersen KF; Shulman GI; Yki-Järvinen H
    Proc Natl Acad Sci U S A; 2020 Mar; 117(13):7347-7354. PubMed ID: 32179679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.